Overview
Sergey Nejentsev practices in Cambridge, United Kingdom. Mr. Nejentsev is rated as an Advanced expert by MediFind in the treatment of Activated PI3K Delta Syndrome (APDS). His top areas of expertise are Lymphoid Hyperplasia, Activated PI3K Delta Syndrome (APDS), Ciliary Dyskinesia-Bronchiectasis, and Lymphofollicular Hyperplasia.
His clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lymphoid HyperplasiaMr. Nejentsev isDistinguished. Learn about Lymphoid Hyperplasia.
- Advanced
- Activated PI3K Delta Syndrome (APDS)Mr. Nejentsev isAdvanced. Learn about Activated PI3K Delta Syndrome (APDS).
- Ciliary Dyskinesia-BronchiectasisMr. Nejentsev isAdvanced. Learn about Ciliary Dyskinesia-Bronchiectasis.
- Experienced
- BronchiectasisMr. Nejentsev isExperienced. Learn about Bronchiectasis.
- Cutis LaxaMr. Nejentsev isExperienced. Learn about Cutis Laxa.
- Drug Induced DyskinesiaMr. Nejentsev isExperienced. Learn about Drug Induced Dyskinesia.
- Lymphofollicular HyperplasiaMr. Nejentsev isExperienced. Learn about Lymphofollicular Hyperplasia.
- Primary Immunodeficiency (PID)Mr. Nejentsev isExperienced. Learn about Primary Immunodeficiency (PID).
- Pulmonary TuberculosisMr. Nejentsev isExperienced. Learn about Pulmonary Tuberculosis.